Baird Medical management commentary cites microwave ablation out-licensing launch as net income turns positive in H1 2026

PUBT · 1d ago
Baird Medical management commentary cites microwave ablation out-licensing launch as net income turns positive in H1 2026
  • Management commentary from Baird Medical Investment Holdings Ltd. cited revenue of USD 9.92 million for the six months ended June 30, 2026.
  • Operating income reached USD 846,806, shifting from an operating loss of USD 10.45 million a year earlier.
  • Net income was USD 13,499, reversing a net loss of USD 11.36 million in the prior-year period.
  • Adjusted EBITDA improved to USD 3.95 million from a loss of USD 3.32 million.
  • Management attributed results to higher revenue, lower total operating expenses, and a new out-licensing initiative for microwave ablation technology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-112109), on September 30, 2026, and is solely responsible for the information contained therein.